National Oncology Program Office
Evidence for cancer treatment is constantly evolving. This can result in lag times for system-wide implementation and variability in treatments for Veterans. Clinical Pathways (CPs) are a decision support tool that bridge this gap by translating published evidence into standardized treatment process maps to help guide treatment decisions.
CPs standardize evidence-based practices to ensure high quality, cost-effective care for Veterans at each point in their care plan. CPs are different from treatment guidelines, as CPs recommend a standard treatment based on efficacy, toxicity, and cost. Guidelines, on the other hand, offer treatment options without always prioritizing specific recommendations. CPs are developed by an interdisciplinary subject matter expert group and approved by national program offices including medical oncology, radiation oncology, surgery, pathology, and pharmacy.
Continue to revisit this page for updates to existing CPs and to find new ones.
Clinical Pathways last updated October 2022.
- Bladder Cancer Clinical Pathway
- Esophageal Cancer Clinical Pathway
- Head and Neck Cancer Clinical Pathway
- Kidney Cancer Clinical Pathway
- Lung Cancer Clinical Pathway
- Prostate Cancer Clinical Pathway
- Salivary Gland Cancer Clinical Pathway
- CLL and SLL Clinical Pathways
- Breast Cancer Clinical Pathway
- Plasma Cell Disorders Clinical Pathway
If you have questions about CPs, please email VHAOncologyPathways@va.gov.